Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for M923 in combination with Humira in chronic plaque-type psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 efficacy and safety results for guselkumab in adults with moderate-to-severe plaque psoriasis have been completed and results posted…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate [Phase 4]
Phase 4 clinical trial evaluating optimization of psoriasis treatment using etanercept in combination with methotrexate; completed.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two dose levels of certolizumab pegol for plaque psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two doses of certolizumab pegol for plaque psoriasis has completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin [Phase 4]
Phase 4 trial assessing capsaicin effects on cutaneous small nerve fibers in psoriatic skin was terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial assessing certolizumab pegol versus active comparator and placebo in plaque psoriasis; study completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Ovarian Reserve in Patients With Psoriasis
A completed clinical trial evaluated ovarian reserve via anti-Müllerian hormone in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects [Phase 1]
Phase 1 safety and pharmacokinetics study of Hemay005, intended for psoriasis, in healthy male subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Evaluating Treatment Resistant Dermatitis TaroIIR [Phase 4]
Phase 4 clinical trial update for treatment-resistant dermatitis (Atopic Dermatitis and Psoriasis) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of combining methotrexate with efalizumab (Raptiva) in psoriasis patients has co…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Biologics Anchoring Study [NA]
Clinical trial update reports that a biologics anchoring study in moderate-to-severe psoriasis has completed. The sponsor is Wake Forest Uni…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Vascular Inflammation in Psoriasis - Extension Study [Phase 4]
This update reports results from an extension Phase 4 study assessing vascular inflammation in people with psoriasis, including those with c…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Vascular Inflammation in Psoriasis Trial (The VIP Trial) [Phase 4]
The VIP Trial (Phase 4) evaluating vascular inflammation in psoriasis has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis [Phase 1, Phase 2]
Phase 1/2 clinical trials explored autologous cytokine-induced killer (CIK) cells as an adoptive immunotherapy for severe psoriasis. The upd…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Topical Psoriasis Study for Patients Receiving Biologic Therapy [Phase 4]
Phase 4 clinical trial update for a topical psoriasis therapy in patients receiving biologic treatment; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis [Phase 1]
Phase 1 multiple ascending dose study of PRX003 in subjects with psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Genetic Analysis of Psoriasis and Psoriatic Arthritis
A completed clinical trial funded by the National Cancer Institute reports genetic analysis findings related to psoriasis and psoriatic arth…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis [Phase 4]
This multicenter, open-label Phase IIIb/IV trial evaluates subcutaneously administered Raptiva (efalizumab) for adults with moderate to seve…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis [Phase 1]
This update reports the completion of a Phase 1 trial evaluating the pharmacokinetics, pharmacodynamics, safety, and tolerability of SB414 i…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis [Phase 3]
Phase 3 trial of ixekizumab in moderate-to-severe genital psoriasis has completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies [Phase 4]
Phase 4 clinical trial update evaluating efalizumab in adults with moderate-to-severe chronic psoriasis who have failed, have a contraindica…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study [Phase 3]
Phase 3 real-world study update evaluating the combination of adalimumab with methotrexate in psoriasis (the CLEAR Study) completed with res…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis [Phase 3]
Phase 3 study evaluating the safety, tolerability, and efficacy of secukinumab for moderate-to-severe nail psoriasis; results have been post…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis [Phase 3]
Polichem S.A. is conducting a Phase 3 trial to evaluate the efficacy and safety of P-3073 Nail Solution for nail psoriasis. The study status…